E8J-93812-77529
5 vaccinations
11 coded responses
47 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 605 / IL
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Registered in v-safe
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-09
- 2021-02-16
-
2021-02-23
Dose 2 — Pfizer-BioNTech
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-05-25
-
2021-08-26
Survey response — 6 months, dose 2MedDRA: Breast cancer, Gallbladder operation — Feeling: Good · Be unable to do your normal daily activitiesFree text: Gallbladder surgery and early breast cancer.No COVID-19 symptoms.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-28
Dose 3 — Pfizer-BioNTech
-
2021-10-28
Survey response — day 0, dose 3MedDRA: Breast cancer — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I am under treatment for breast cancer now.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Fatiguev is chronic, aecondary to my meds, not the vacciinenMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Fatigue is chronic since I started chemotherapy 6 weeks before the booster shot.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue, Pre-existing disease — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Fatigue is chronic ; I take cancer meds.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Fatigue is chronic due to chemotherapy.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Fatige is chronic due to chemotherapyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Survey response — day 7, dose 3MedDRA: Pre-existing disease — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Fatigue is chronic, from chemotherapyMedDRA releases: 2024-11 · check-in free text available
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2021-12-02
Survey response — day 35, dose 3MedDRA: Chemotherapy, Fatigue, Pre-existing disease, Rash — Feeling: Good · Be unable to do your normal daily activitiesFree text: Rash and fatigue due to chemo for cancetMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Survey response — day 42, dose 3MedDRA: Fatigue, Rash — Feeling: Good · Be unable to do your normal daily activitiesFree text: Rash possibly related to chemo med. Fatigue, worsened with antihistamine for rash.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Survey response — 3 months, dose 3MedDRA: Office visit, Pre-existing disease, Rash — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rash (resolved), not related to COVID, cause unknown and resolved after initiation of antihistamine. Also esophagitis under treatment and chronic for many years. No respiratory symptoms. I have cancer since 3-2021. · Healthcare visit (other): Saw dermatoogist in officeMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-31
-
2022-04-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-28
-
2022-04-29
Dose 4 — Pfizer-BioNTech
- 2022-05-18
- 2022-05-20
- 2022-05-29
- 2022-06-03
- 2022-06-10
- 2022-07-29
-
2022-09-12
Dose 5 — Pfizer-BioNTech
- 2022-10-17
- 2022-10-24
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
| 4 | 2022-04-29 | Pfizer-BioNTech | No |
| 5 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Gallbladder surgery and early breast cancer.No COVID-19 symptoms.
Release 10 — day 0, dose 3
Systemic reaction (other): I am under treatment for breast cancer now.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Fatiguev is chronic, aecondary to my meds, not the vacciinen
Systemic reaction (other): Fatigue is chronic since I started chemotherapy 6 weeks before the booster shot.
Systemic reaction (other): Fatigue is chronic ; I take cancer meds.
Systemic reaction (other): Fatigue is chronic due to chemotherapy.
Systemic reaction (other): Fatige is chronic due to chemotherapy
Release 10 — day 7, dose 3
Systemic reaction (other): Fatigue is chronic, from chemotherapy
Release 10 — day 35, dose 3
Symptoms: Rash and fatigue due to chemo for cancet
Release 10 — day 42, dose 3
Symptoms: Rash possibly related to chemo med. Fatigue, worsened with antihistamine for rash.
Release 11 — 3 months, dose 3
Symptoms: Rash (resolved), not related to COVID, cause unknown and resolved after initiation of antihistamine. Also esophagitis under treatment and chronic for many years. No respiratory symptoms. I have cancer since 3-2021.
Healthcare visit (other): Saw dermatoogist in office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Breast cancer | ✓ | · | ✓ |
| SD | Chemotherapy | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gallbladder operation | ✓ | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SRO | Breast cancer | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release